Terms: = Breast cancer AND SMO, Q99835, 6608, ENSG00000128602, SMOH, Gx AND Treatment
43 results:
1. Performance analysis of data resampling on class imbalance and classification techniques on multi-omics data for cancer classification.
Yang Y; Mirzaei G
PLoS One; 2024; 19(2):e0293607. PubMed ID: 38422094
[TBL] [Abstract] [Full Text] [Related]
2. Current Status of Hedgehog Signaling Inhibitors.
Wang X; Wang T; Song X; Gao J; Xu G; Ma Y; Song G
Curr Top Med Chem; 2024; 24(3):243-258. PubMed ID: 38231069
[TBL] [Abstract] [Full Text] [Related]
3. Evaluating the Correlation of Hedgehog Pathway with Claudin-1 Expression in Invasive breast cancer.
Chen D; Cheng X
Cell Mol Biol (Noisy-le-grand); 2023 Feb; 69(2):60-66. PubMed ID: 37224045
[TBL] [Abstract] [Full Text] [Related]
4. Genetic mutations in HER2-positive breast cancer: possible association with response to trastuzumab therapy.
Zakaria NH; Hashad D; Saied MH; Hegazy N; Elkayal A; Tayae E
Hum Genomics; 2023 May; 17(1):43. PubMed ID: 37202799
[TBL] [Abstract] [Full Text] [Related]
5. Emerging Roles of Hedgehog Signaling in cancer Immunity.
Giammona A; Crivaro E; Stecca B
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674836
[TBL] [Abstract] [Full Text] [Related]
6. Stem gene expression in breast tumors during chemotherapy: Connection with the main clinical and morphological factors and the disease outcome.
Ibragimova MK; Tsyganov MM; Deryusheva IV; Slonimskaya EM; Litviakov NV
J Cancer Res Ther; 2022; 18(1):89-95. PubMed ID: 35381768
[TBL] [Abstract] [Full Text] [Related]
7. Interval breast cancer is associated with interferon immune response.
Ugalde-Morales E; Grassmann F; Humphreys K; Li J; Eriksson M; Tobin NP; Lindström LS; Vallon-Christersson J; Borg Å; Hall P; Czene K
Eur J Cancer; 2022 Feb; 162():194-205. PubMed ID: 35026490
[TBL] [Abstract] [Full Text] [Related]
8. Physalin A, 13,14-Seco-16, 24-Cyclo-Steroid, Inhibits Stemness of breast cancer Cells by Regulation of Hedgehog Signaling Pathway and Yes-Associated Protein 1 (YAP1).
Ko YC; Choi HS; Liu R; Lee DS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445421
[TBL] [Abstract] [Full Text] [Related]
9. Alternations of N-glycans recognized by Phaseolus vulgaris leucoagglutinin in the saliva of patients with breast cancer.
Yang J; Ma T; Yu H; Yin M; Qiao Y; Niu L; Yang F; He J; Li Z
Neoplasma; 2021 Sep; 68(5):994-1004. PubMed ID: 34374293
[TBL] [Abstract] [Full Text] [Related]
10. Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation.
Li L; Bao J; Wang H; Lei JH; Peng C; Zeng J; Hao W; Zhang X; Xu X; Yu C; Deng CX; Chen Q
Theranostics; 2021; 11(4):1672-1689. PubMed ID: 33408774
[No Abstract] [Full Text] [Related]
11. Combined inhibition of JAK2-STAT3 and smo-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis.
Doheny D; Sirkisoon S; Carpenter RL; Aguayo NR; Regua AT; Anguelov M; Manore SG; Arrigo A; Jalboush SA; Wong GL; Yu Y; Wagner CJ; Chan M; Ruiz J; Thomas A; Strowd R; Lin J; Lo HW
Oncogene; 2020 Oct; 39(42):6589-6605. PubMed ID: 32929154
[TBL] [Abstract] [Full Text] [Related]
12. Discovery of [1,2,4]triazolo[4,3-a]pyridines as potent smoothened inhibitors targeting the Hedgehog pathway with improved antitumor activity in vivo.
Tian N; Wu H; Zhang H; Yang D; Lv L; Yang Z; Zhang T; Quan D; Zhou L; Xie Y; Xu Y; Wei N; Zhang J; Chen M; Schmitz JC; Tian Y; Wu S
Bioorg Med Chem; 2020 Aug; 28(16):115584. PubMed ID: 32690258
[TBL] [Abstract] [Full Text] [Related]
13. Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study.
Kurzrock R; Bowles DW; Kang H; Meric-Bernstam F; Hainsworth J; Spigel DR; Bose R; Burris H; Sweeney CJ; Beattie MS; Blotner S; Schulze K; Cuchelkar V; Swanton C
Ann Oncol; 2020 Mar; 31(3):412-421. PubMed ID: 32067683
[TBL] [Abstract] [Full Text] [Related]
14. TSPAN8 promotes cancer cell stemness via activation of sonic Hedgehog signaling.
Zhu R; Gires O; Zhu L; Liu J; Li J; Yang H; Ju G; Huang J; Ge W; Chen Y; Lu Z; Wang H
Nat Commun; 2019 Jun; 10(1):2863. PubMed ID: 31253779
[TBL] [Abstract] [Full Text] [Related]
15. Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers.
Katoh M
Clin Sci (Lond); 2019 Apr; 133(8):953-970. PubMed ID: 31036756
[TBL] [Abstract] [Full Text] [Related]
16. Classifying breast cancer Subtypes Using Multiple Kernel Learning Based on Omics Data.
Tao M; Song T; Du W; Han S; Zuo C; Li Y; Wang Y; Yang Z
Genes (Basel); 2019 Mar; 10(3):. PubMed ID: 30866472
[TBL] [Abstract] [Full Text] [Related]
17. Immunohistochemical Evaluation of Ki-67 and Comparison with Clinicopathologic Factors in breast Carcinomas.
Aman NA; Doukoure B; Koffi KD; Koui BS; Traore ZC; Kouyate M; Toure I; Effi AB
Asian Pac J Cancer Prev; 2019 Jan; 20(1):73-79. PubMed ID: 30678383
[TBL] [Abstract] [Full Text] [Related]
18. Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity.
Qin T; Li B; Feng X; Fan S; Liu L; Liu D; Mao J; Lu Y; Yang J; Yu X; Zhang Q; Zhang J; Song B; Li M; Li L
J Exp Clin Cancer Res; 2018 Nov; 37(1):287. PubMed ID: 30482232
[TBL] [Abstract] [Full Text] [Related]
19. Vismodegib.
Meiss F; Andrlová H; Zeiser R
Recent Results Cancer Res; 2018; 211():125-139. PubMed ID: 30069764
[TBL] [Abstract] [Full Text] [Related]
20. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
[TBL] [Abstract] [Full Text] [Related]
[Next]
